The new facility will manufacture rapid diagnostic tests used in several areas of healthcare, including the detection of infectious diseases and epidemics, drug screening and the identification of cancer biomarkers.
The new facility will manufacture rapid diagnostic tests used in several areas of healthcare, including the detection of infectious diseases and epidemics, drug screening and the identification of cancer biomarkers.